Navigation Links
£1.2M trial to test effectiveness of cognitive behavioral therapy
Date:5/30/2008

A team of researchers, led by Dr Nicola Wiles at the University of Bristol and involving researchers from the Peninsula Medical School in the South West, has been awarded 1.2 million by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme for a clinical trial to investigate the effectiveness of cognitive behavioural therapy (CBT) for patients with depression who do not respond to treatment with antidepressants.

Patients who have been taking antidepressants for at least six weeks will be invited to participate in the trial and receive either CBT in addition to their medication, or continue with usual care from their general practitioner (including medication). Both groups will be followed up for 12 months to see which approach is the most effective in reducing depressive symptoms and improving quality of life. Recruitment for the trial is due to start in the autumn.

The Bristol team, in partnership with researchers from the University of Exeter, the Peninsula Medical School, the University of Glasgow and the Avon and Wiltshire Mental Health Partnership, will also evaluate the cost-effectiveness of the treatment and patients' views and experiences of it.

Dr Nicola Wiles said: "CBT has been shown to help patients with depression but there is currently little evidence about what alternative treatment options doctors should discuss with patients who do not get better with antidepressants. Improving access to psychological therapies is a Government priority, so it is important that we conduct studies such as this to help inform the care of people with depression."

Professor Campbell (Peninsula Medical School) said: "This study offers the opportunity for patients in the South West to contribute to an important piece of research which will help define the best mode of treatment for patients suffering from depression. The study will bring together a team of researchers from Peninsula Medical School and the University of Exeter (led by Professor Kuyken) in an exciting new venture ultimately aimed at improving patient care in the South West Peninsula"

This trial is one of three new research projects being funded by the NIHR HTA programme to expand the evidence base surrounding the effectiveness of CBT for the treatment of depression. A combination of psychotherapy and behavioural therapy, CBT works by changing people's attitudes and behaviour by focusing on their thoughts, beliefs and attitudes and how these relate to the way they behave. Existing research suggests that CBT may be effective in tackling depression, but more evidence is needed.


'/>"/>

Contact: Andrew Gould
media@pr-works.co.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Related medicine news :

1. New Heart Pump Shows Promise in Trial
2. Trial to Test Gene Therapy for Angina in Women
3. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
4. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. MDS Pharma Services Wins Award for Management of Global Malaria Trial
7. New Ovarian Cancer Drug Trial Under Way
8. Study Questions Dead-End Cancer Clinical Trials
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
11. Clinical trials present better alternatives for dialysis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... Warren L. Smith M.D. , There ... UTIs, have plagued people since the beginning of recorded medical history, and in ... every year. It's not just a matter of inconvenience; bladder infections cost us billions ...
(Date:5/4/2016)... , ... May 03, ... manufacturer of innovative infant and child products, today revealed the non-toxic ... ability to help babies deal with teething pain is just part ... no toxic gels, and are BPA-, PVC-, and phthalate-free. , ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... Patient 2016, a powerful cellular therapy software application that helps blood and ... to patients. , Since Transtem’s initial launch, Mediware has continued to enhance core ...
(Date:5/4/2016)... ... 04, 2016 , ... With the stamp of approval from the United States ... National Cancer Research Month. According to the American Cancer Society (2016) , this ... one in four Americans dying as a result. , With numbers as influential as ...
(Date:5/4/2016)... ... May 04, 2016 , ... DESCO ... acquired Pocono Sterilizer, an equipment sterilization service and sales company located in Pennsylvania. ... medical and research-related equipment and asset management services to the medical and academic ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 4, 2016 ... across 154 pages, profiling 09 key companies and ... a professional and in-depth study on the current ... basic overview of the industry including definitions, classifications, ... market analysis is provided for the international market ...
(Date:5/3/2016)... Mo. , May 3, 2016 ... Medical Center,s Institute for Advancing Medical Innovation (IAMI) ... commercialize new drugs, diagnostics and medical devices. ... BioNovus Innovations with rights to license, develop and ... "This partnership represents a ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: